查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933307

全球颅内动脉瘤市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察、未来预测（2026-2034）

Intracranial Aneurysm Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 请询问到货日

价格

颅内动脉瘤市场成长因素

由于脑血管疾病盛行率的上升、早期诊断意识的增强以及微创神经血管治疗技术的快速发展，全球颅内动脉瘤市场正经历稳定成长。该市场规模在2025年达到17.4亿美元，预计从2026年的18.7亿美元成长至2034年的29.5亿美元，预测期内年复合成长率（CAGR）为5.90%。凭藉强大的医疗基础设施、积极的研究活动以及先进动脉瘤治疗设备的高普及率，北美在2025年占据了43.70%的市场占有率，成为全球主导市场。

市场概览

颅内动脉瘤（脑动脉瘤）是指脑血管壁薄弱导致的血管膨胀，呈球状。动脉瘤破裂可导致严重的内出血，危及生命。治疗方案包括显微外科夹闭术和微创血管内手术，例如栓塞术、支架置入术和血流导向装置。患者和医疗专业人员对这些治疗方法的认识不断提高，显着推动了全球对颅内动脉瘤治疗设备的需求。

根据脑动脉瘤基金会（2023年）的资料，美国约有 670万人患有未破裂的脑动脉瘤，凸显了需要诊断和治疗的患者群体庞大。

新冠疫情的影响

由于选择性神经血管手术减少以及医疗器械供应链中断，新冠疫情对颅内动脉瘤市场产生了负面影响。疫情期间手术量的下降导致市场成长放缓。然而，随着医院服务的逐步恢復以及延迟的神经血管介入手术的实施，疫情后市场趋于稳定。

市场趋势

影响市场的关键趋势是微创手术越来越受欢迎。传统的开颅手术和动脉瘤夹闭术正逐渐被血管内治疗技术所取代，例如栓塞术和血流导引装置，这些技术可以缩短恢復时间并降低手术风险。血流导向装置的技术进步已将其应用范围从复杂动脉瘤扩展到中小尺寸病变，刺激了医疗器材製造商的采用率和创新。

市场成长驱动因素

全球脑动脉瘤发生率的不断上升是市场成长的主要驱动因素。磁振造影血管摄影（MRA）和3D血管摄影等先进影像诊断技术的进步提高了早期检出率，导致寻求治疗的患者人数不断增加。此外，公共和私人机构对动脉瘤研究的大力支持也加速了创新。研究经费和长期临床研究推动下一代治疗设备的研发，这些设备具有更高的安全性和有效性。

在日本等国家，动脉瘤破裂的高风险促使早期筛检计画的进行，并增加了对动脉瘤治疗器械的需求。

限制因子

儘管技术不断进步，误诊和高昂的治疗费用仍然是主要挑战。治疗破裂动脉瘤的成本远高于治疗未破裂动脉瘤。此外，发展中地区认知度低、缺乏标准化的诊断指南以及医疗基础设施不足，导致诊断延迟，阻碍了市场的广泛普及。

细分市场分析

依产品类型划分，动脉瘤治疗器械在2026年将占据44.39%的市场占有率，这主要得益于弹簧圈、夹子、血流导引装置和血管内治疗器械的高普及率。按动脉瘤类型划分，囊状动脉瘤是最常见的诊断类型，预计到2026年将占 90.91%的市场占有率。依终端用户划分，医院将凭藉其技术精湛的专家和先进的神经血管治疗设施，在2026年占据 72.19%的市场占有率，成为市场主导力量。

区域洞察

到2025年，北美市场规模达到 7.6亿美元，这得益于强有力的宣传活动、微创手术的早期应用以及积极的研发活动。欧洲紧随其后，这主要得益于欧盟资助的研究计画和许多创新新创公司。亚太地区预计将以最高的年复合成长率成长，这主要归功于印度和中国等国家较高的疾病负担、不断扩大的医疗保健覆盖范围以及较低的手术成本。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 主要外科手术数（2026年）
  • 主要公司新产品发表数量
  • 关键趋势：併购、商业合作
  • 颅内动脉瘤治疗设备的技术进步
  • COVID-19 的影响市场

第5章 全球颅内动脉瘤市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品类型划分
    • 动脉瘤治疗器械
      • 动脉瘤夹
      • 动脉瘤弹簧圈
      • 血管内治疗器械
      • 血流导向装置
    • 栓塞器械
      • 闭塞导管
      • 栓塞剂
    • 抽吸器械
      • 抽吸导管
      • 血栓切除器械
    • 入路器械
      • 微导管
      • 导丝
    预测：依类型
    • 囊状动脉瘤
    • 梭形动脉瘤
    • 真菌性动脉瘤
  • 市场分析、洞察与预测：依最终用户
    • 医院
    • 专科诊所
    • 其他
  • 市场分析、洞察与预测：依地区
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美颅内动脉瘤市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 美国各州
    • 加拿大

第7章 欧洲颅内动脉瘤市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲国家

第8章 亚太地区颅内动脉瘤市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 澳洲
    • 中国
    • 印度
    • 亚太其他地区

第9章 拉丁美洲颅内动脉瘤市场分析动脉瘤市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第10章 中东与非洲颅内动脉瘤市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • GCC国家
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市场占有率分析（2026）
  • 公司简介
    • Medtronic
    • B. Braun SE
    • Integra LifeSciences
    • MicroPort Scientific Corporation
    • Stryker
    • Johnson & Johnson Services, Inc.
    • Terumo Corporation（MicroVention Inc.）
    • Evasc Neurovascular Enterprises
    • Penumbra, Inc.
Product Code: FBI109526

Growth Factors of intracranial aneurysm Market

The global intracranial aneurysm market is witnessing steady growth due to the rising prevalence of cerebrovascular diseases, increasing awareness of early diagnosis, and rapid advancements in minimally invasive neurovascular treatment technologies. The market was valued at USD 1.74 billion in 2025 and is projected to grow from USD 1.87 billion in 2026 to USD 2.95 billion by 2034, registering a CAGR of 5.90% during the forecast period. North America dominated the market with a 43.70% share in 2025, supported by strong healthcare infrastructure, active research initiatives, and high adoption of advanced aneurysm treatment devices.

Market Overview

An intracranial or cerebral aneurysm is a balloon-like dilation of blood vessels in the brain caused by weakened vessel walls. If ruptured, it can lead to severe internal bleeding and can be life-threatening. Treatment options include microsurgical clipping and minimally invasive endovascular procedures such as coiling, stenting, and flow diversion. Increasing awareness among patients and healthcare providers regarding these treatment approaches is significantly boosting demand for intracranial aneurysm devices globally.

According to the Brain Aneurysm Foundation (2023), approximately 6.7 million people in the U.S. live with an unruptured brain aneurysm, highlighting the large patient pool requiring diagnosis and treatment.

Impact of COVID-19

The COVID-19 pandemic negatively affected the intracranial aneurysm market due to reduced elective neurovascular procedures and disruptions in the supply chain of medical devices. A decline in procedure volumes during the pandemic led to slower market growth. However, the gradual resumption of hospital services and delayed neurovascular interventions helped the market regain stability post-pandemic.

Market Trends

A major trend shaping the market is the growing preference for minimally invasive procedures. Traditional craniotomy and clipping methods are increasingly being replaced by endovascular techniques such as coiling and flow diversion, which reduce recovery time and procedural risks. Technological advancements in flow diverters have expanded their use from complex aneurysms to small and medium-sized lesions, driving higher adoption and encouraging innovation among device manufacturers.

Market Growth Drivers

The increasing prevalence of cerebral aneurysms globally is a key driver of market growth. Advanced imaging technologies such as magnetic resonance angiography and 3D angiography have improved early detection rates, increasing the number of patients seeking treatment. Additionally, strong support from public and private organizations for aneurysm research is accelerating innovation. Research grants and long-term clinical studies are enabling the development of next-generation therapeutic devices with improved safety and efficacy.

Countries such as Japan show a higher risk of aneurysm rupture, which has led to early screening programs and increased demand for aneurysm treatment devices.

Restraining Factors

Despite technological progress, misdiagnosis and high treatment costs remain significant challenges. Treating ruptured aneurysms is substantially more expensive than managing unruptured cases. Moreover, limited awareness, lack of standardized diagnostic guidelines, and inadequate healthcare infrastructure in developing regions contribute to delayed diagnosis, restricting broader market penetration.

Segmentation Analysis

By product type, aneurysm therapeutic devices dominated the market with a 44.39% share in 2026, driven by high adoption of coils, clips, flow diverters, and intravascular devices. Based on aneurysm type, saccular aneurysms accounted for 90.91% of the market in 2026, as they are the most commonly diagnosed form. By end-user, hospitals led the market with a 72.19% share in 2026, owing to the availability of skilled professionals and advanced neurovascular treatment facilities.

Regional Insights

North America generated USD 0.76 billion in 2025, driven by strong awareness programs, early adoption of minimally invasive procedures, and robust R&D activity. Europe followed, supported by EU-funded research initiatives and innovation-driven startups. Asia Pacific is expected to grow at the highest CAGR, due to a high disease burden, expanding healthcare access, and lower surgical costs in countries such as India and China.

Competitive Landscape

The market is highly consolidated, with Stryker, Medtronic, and Terumo Corporation leading globally. These companies are focused on acquisitions, partnerships, and new product launches to strengthen their portfolios. Emerging players are also investing heavily in R&D to establish their presence in the neurovascular devices market.

Conclusion

The global intracranial aneurysm market is poised for consistent growth, expanding from USD 1.74 billion in 2025 to USD 2.95 billion by 2034, driven by rising prevalence of cerebral aneurysms, growing preference for minimally invasive treatments, and continuous technological advancements. While challenges such as misdiagnosis and high treatment costs persist, increasing research funding, improved diagnostic capabilities, and expanding healthcare infrastructure are expected to support sustained market growth throughout the forecast period.

Segmentation By Product Type

  • Aneurysm Therapeutic Devices
    • Clips
    • Coils
    • Intravascular Devices
    • Flow Diverter
  • Embolization Devices
    • Occlusion Catheters
    • Embolic Agent
  • Aspiration Devices
    • Aspiration Catheter
    • Clot Retrieval Device
  • Access Devices
    • Micro Catheter
    • Guidewire

By Type

  • Saccular aneurysm
  • Fusiform aneurysm
  • Mycotic aneurysm

By End-User

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America (By Product Type, Type, End-User, and Country)
    • U.S.
    • Canada
  • Europe (By Product Type, Type, End-User, and Country)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (By Product Type, Type, End-User, and Country)
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Product Type, Type, End-User, and Country)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, Type, End-User, and Country)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Key Surgical Procedures, 2026
  • 4.2. New Product Launches, By Key Players
  • 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.4. Technological Advancement in Intracranial Aneurysm Devices
  • 4.5. Impact of COVID-19 on the Market

5. Global Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Aneurysm Therapeutic Devices
      • 5.1.1.1. Clips
      • 5.1.1.2. Coils
      • 5.1.1.3. Intravascular Devices
      • 5.1.1.4. Flow Diverter
    • 5.1.2. Embolization Devices
      • 5.1.2.1. Occlusion Catheters
      • 5.1.2.2. Embolic Agent
    • 5.1.3. Aspiration Devices
      • 5.1.3.1. Aspiration Catheter
      • 5.1.3.2. Clot Retrieval Device
    • 5.1.4. Access Devices
      • 5.1.4.1. Micro Catheter
      • 5.1.4.2. Guidewire
  • 5.2. Market Analysis, Insights and Forecast - By Type
    • 5.2.1. Saccular aneurysm
    • 5.2.2. Fusiform aneurysm
    • 5.2.3. Mycotic aneurysm
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Aneurysm Therapeutic Devices
      • 6.1.1.1. Clips
      • 6.1.1.2. Coils
      • 6.1.1.3. Intravascular Devices
      • 6.1.1.4. Flow Diverter
    • 6.1.2. Embolization Devices
      • 6.1.2.1. Occlusion Catheters
      • 6.1.2.2. Embolic Agent
    • 6.1.3. Aspiration Devices
      • 6.1.3.1. Aspiration Catheter
      • 6.1.3.2. Clot Retrieval Device
    • 6.1.4. Access Devices
      • 6.1.4.1. Micro Catheter
      • 6.1.4.2. Guidewire
  • 6.2. Market Analysis, Insights and Forecast - By Type
    • 6.2.1. Saccular aneurysm
    • 6.2.2. Fusiform aneurysm
    • 6.2.3. Mycotic aneurysm
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Aneurysm Therapeutic Devices
      • 7.1.1.1. Clips
      • 7.1.1.2. Coils
      • 7.1.1.3. Intravascular Devices
      • 7.1.1.4. Flow Diverter
    • 7.1.2. Embolization Devices
      • 7.1.2.1. Occlusion Catheters
      • 7.1.2.2. Embolic Agent
    • 7.1.3. Aspiration Devices
      • 7.1.3.1. Aspiration Catheter
      • 7.1.3.2. Clot Retrieval Device
    • 7.1.4. Access Devices
      • 7.1.4.1. Micro Catheter
      • 7.1.4.2. Guidewire
  • 7.2. Market Analysis, Insights and Forecast - By Type
    • 7.2.1. Saccular aneurysm
    • 7.2.2. Fusiform aneurysm
    • 7.2.3. Mycotic aneurysm
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Rest of Europe

8. Asia pacific Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Aneurysm Therapeutic Devices
      • 8.1.1.1. Clips
      • 8.1.1.2. Coils
      • 8.1.1.3. Intravascular Devices
      • 8.1.1.4. Flow Diverter
    • 8.1.2. Embolization Devices
      • 8.1.2.1. Occlusion Catheters
      • 8.1.2.2. Embolic Agent
    • 8.1.3. Aspiration Devices
      • 8.1.3.1. Aspiration Catheter
      • 8.1.3.2. Clot Retrieval Device
    • 8.1.4. Access Devices
      • 8.1.4.1. Micro Catheter
      • 8.1.4.2. Guidewire
  • 8.2. Market Analysis, Insights and Forecast - By Type
    • 8.2.1. Saccular aneurysm
    • 8.2.2. Fusiform aneurysm
    • 8.2.3. Mycotic aneurysm
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. Australia
    • 8.4.3. China
    • 8.4.4. India
    • 8.4.5. Rest of Asia Pacific

9. Latin America Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Aneurysm Therapeutic Devices
      • 9.1.1.1. Clips
      • 9.1.1.2. Coils
      • 9.1.1.3. Intravascular Devices
      • 9.1.1.4. Flow Diverter
    • 9.1.2. Embolization Devices
      • 9.1.2.1. Occlusion Catheters
      • 9.1.2.2. Embolic Agent
    • 9.1.3. Aspiration Devices
      • 9.1.3.1. Aspiration Catheter
      • 9.1.3.2. Clot Retrieval Device
    • 9.1.4. Access Devices
      • 9.1.4.1. Micro Catheter
      • 9.1.4.2. Guidewire
  • 9.2. Market Analysis, Insights and Forecast - By Type
    • 9.2.1. Saccular aneurysm
    • 9.2.2. Fusiform aneurysm
    • 9.2.3. Mycotic aneurysm
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Aneurysm Therapeutic Devices
      • 10.1.1.1. Clips
      • 10.1.1.2. Coils
      • 10.1.1.3. Intravascular Devices
      • 10.1.1.4. Flow Diverter
    • 10.1.2. Embolization Devices
      • 10.1.2.1. Occlusion Catheters
      • 10.1.2.2. Embolic Agent
    • 10.1.3. Aspiration Devices
      • 10.1.3.1. Aspiration Catheter
      • 10.1.3.2. Clot Retrieval Device
    • 10.1.4. Access Devices
      • 10.1.4.1. Micro Catheter
      • 10.1.4.2. Guidewire
  • 10.2. Market Analysis, Insights and Forecast - By Type
    • 10.2.1. Saccular aneurysm
    • 10.2.2. Fusiform aneurysm
    • 10.2.3. Mycotic aneurysm
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2026)
  • 11.2. Company Profiles
    • 11.2.1. Medtronic
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. B. Braun SE
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Integra LifeSciences
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. MicroPort Scientific Corporation
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Stryker
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Johnson & Johnson Services, Inc.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Terumo Corporation (MicroVention Inc.)
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Evasc Neurovascular Enterprises
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Penumbra, Inc.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aneurysm Therapeutic Devices, 2021-2034
  • Table 3: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Embolization Devices, 2021-2034
  • Table 4: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aspiration Devices, 2021-2034
  • Table 5: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Access Devices, 2021-2034
  • Table 6: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 7: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 8: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 9: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 10: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aneurysm Therapeutic Devices, 2021-2034
  • Table 11: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Embolization Devices, 2021-2034
  • Table 12: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aspiration Devices, 2021-2034
  • Table 13: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Access Devices, 2021-2034
  • Table 14: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 15: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 16: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 17: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 18: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aneurysm Therapeutic Devices, 2021-2034
  • Table 19: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Embolization Devices, 2021-2034
  • Table 20: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aspiration Devices, 2021-2034
  • Table 21: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Access Devices, 2021-2034
  • Table 22: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 23: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 24: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 26: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aneurysm Therapeutic Devices, 2021-2034
  • Table 27: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Embolization Devices, 2021-2034
  • Table 28: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aspiration Devices, 2021-2034
  • Table 29: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Access Devices, 2021-2034
  • Table 30: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 31: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 32: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 33: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 34: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aneurysm Therapeutic Devices, 2021-2034
  • Table 35: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Embolization Devices, 2021-2034
  • Table 36: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aspiration Devices, 2021-2034
  • Table 37: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Access Devices, 2021-2034
  • Table 38: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 39: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 40: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 41: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 42: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aneurysm Therapeutic Devices, 2021-2034
  • Table 43: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Embolization Devices, 2021-2034
  • Table 44: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aspiration Devices, 2021-2034
  • Table 45: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Access Devices, 2021-2034
  • Table 46: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 47: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 48: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Intracranial Aneurysm Market Revenue Breakdown (USD billion, %) by Region, 2026 & 2034
  • Figure 2: Global Intracranial Aneurysm Market Value Share (%), by Product Type, 2026 & 2034
  • Figure 3: Global Intracranial Aneurysm Market Forecast (USD billion), by Aneurysm Therapeutic Devices, 2021-2034
  • Figure 4: Global Intracranial Aneurysm Market Forecast (USD billion), by Embolization Devices, 2021-2034
  • Figure 5: Global Intracranial Aneurysm Market Forecast (USD billion), by Aspiration Devices, 2021-2034
  • Figure 6: Global Intracranial Aneurysm Market Forecast (USD billion), by Access Devices, 2021-2034
  • Figure 7: Global Intracranial Aneurysm Market Value Share (%), by Type, 2026 & 2034
  • Figure 8: Global Intracranial Aneurysm Market Value Share (%), by End-user, 2026 & 2034
  • Figure 9: Global Intracranial Aneurysm Market Value (USD billion), by Region, 2026 & 2034
  • Figure 10: North America Intracranial Aneurysm Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 11: North America Intracranial Aneurysm Market Value Share (%), by Product Type, 2026
  • Figure 12: North America Intracranial Aneurysm Market Value (USD billion), by Type, 2026 & 2034
  • Figure 13: North America Intracranial Aneurysm Market Value Share (%), by Type, 2026
  • Figure 14: North America Intracranial Aneurysm Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 15: North America Intracranial Aneurysm Market Value Share (%), by End-user, 2026
  • Figure 16: North America Intracranial Aneurysm Market Value (USD billion), By Country, 2026 & 2034
  • Figure 17: North America Intracranial Aneurysm Market Value Share (%), By Country, 2026
  • Figure 18: Europe Intracranial Aneurysm Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 19: Europe Intracranial Aneurysm Market Value Share (%), by Product Type, 2026
  • Figure 20: Europe Intracranial Aneurysm Market Value (USD billion), by Type, 2026 & 2034
  • Figure 21: Europe Intracranial Aneurysm Market Value Share (%), by Type, 2026
  • Figure 22: Europe Intracranial Aneurysm Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 23: Europe Intracranial Aneurysm Market Value Share (%), by End-user, 2026
  • Figure 24: Europe Intracranial Aneurysm Market Value (USD billion), By Country/ Sub-region, 2026 & 2034
  • Figure 25: Europe Intracranial Aneurysm Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 26: Asia Pacific Intracranial Aneurysm Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 27: Asia Pacific Intracranial Aneurysm Market Value Share (%), by Product Type, 2026
  • Figure 28: Asia Pacific Intracranial Aneurysm Market Value (USD billion), by Type, 2026 & 2034
  • Figure 29: Asia Pacific Intracranial Aneurysm Market Value Share (%), by Type, 2026
  • Figure 30: Asia Pacific Intracranial Aneurysm Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 31: Asia Pacific Intracranial Aneurysm Market Value Share (%), by End-user, 2026
  • Figure 32: Asia Pacific Intracranial Aneurysm Market Value (USD billion), By Country/ Sub-region, 2026 & 2034
  • Figure 33: Asia Pacific Intracranial Aneurysm Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 34: Latin America Intracranial Aneurysm Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 35: Latin America Intracranial Aneurysm Market Value Share (%), by Product Type, 2026
  • Figure 36: Latin America Intracranial Aneurysm Market Value (USD billion), by Type, 2026 & 2034
  • Figure 37: Latin America Intracranial Aneurysm Market Value Share (%), by Type, 2026
  • Figure 38: Latin America Intracranial Aneurysm Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 39: Latin America Intracranial Aneurysm Market Value Share (%), by End-user, 2026
  • Figure 40: Latin America Intracranial Aneurysm Market Value (USD billion), By Country/ Sub-region, 2026 & 2034
  • Figure 41: Latin America Intracranial Aneurysm Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 42: Middle East & Africa Intracranial Aneurysm Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 43: Middle East & Africa Intracranial Aneurysm Market Value Share (%), by Product Type, 2026
  • Figure 44: Middle East & Africa Intracranial Aneurysm Market Value (USD billion), by Type, 2026 & 2034
  • Figure 45: Middle East & Africa Intracranial Aneurysm Market Value Share (%), by Type, 2026
  • Figure 46: Middle East & Africa Intracranial Aneurysm Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 47: Middle East & Africa Intracranial Aneurysm Market Value Share (%), by End-user, 2026
  • Figure 48: Middle East & Africa Intracranial Aneurysm Market Value (USD billion), By Country/ Sub-region, 2026 & 2034
  • Figure 49: Middle East & Africa Intracranial Aneurysm Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 50: Global Intracranial Aneurysm Market Share (%), By Company, 2026